Upper extremity aerobic exercise for patients with interstitial lung disease
Investigation of the Effects of Upper Extremity Aerobic Exercise Training on Oxygen Consumption, Muscle Oxygenation and Physical Activity in Patients With Interstitial Lung Disease
This study tests whether high-intensity upper body exercise can help people with interstitial lung disease feel better and improve their daily activities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 42 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Gazi University Academic / other |
| Locations | 1 site (Ankara, Çankaya) |
| Trial ID | NCT05916404 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of upper extremity high-intensity interval aerobic exercise training on patients diagnosed with interstitial lung disease (ILD). It aims to address the exercise intolerance and decreased physical activity levels commonly experienced by these patients due to their condition. By focusing on upper extremity exercises, the study seeks to improve functional performance and overall quality of life for individuals with ILD. Participants will be compared to a control group to assess the effectiveness of the intervention.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-75 diagnosed with interstitial lung disease who are not currently experiencing pulmonary infections.
Not a fit: Patients with significant comorbidities or recent acute pulmonary exacerbations may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance physical function and reduce symptoms in patients with interstitial lung disease.
How similar studies have performed: While exercise training has shown benefits in ILD patients, this specific focus on upper extremity aerobic exercise is a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with ILD according to ATS/ERS criteria, * Aged between 18-75 years, * No pulmonary infection during the last month, * Patients who volunteer to participate in the study Exclusion Criteria: Patients with, * Body mass index \>35 kg/m2, * An acute pulmonary exacerbation within the last 4 weeks, have an acute upper or lower respiratory tract infection, * Presence of obstructive pulmonary disease, * Serious neurological, neuromuscular, orthopedic, or other diseases affecting physical functions, * Participated in a planned exercise program within the last three months, * Cognitive impairment that causes them to have difficulty understanding and following exercise test instructions, * Contraindications for exercise testing and/or exercise training according to the American College of Sports Medicine * Cancer, renal or hepatic diseases, * Aortic stenosis, complex arrhythmia, with aortic aneurysm, * Uncontrolled hypertension, diabetes mellitus, heart failure, arrhythmia and serious cardiovascular disease
Where this trial is running
Ankara, Çankaya
- Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit — Ankara, Çankaya, Turkey (Recruiting)
Study contacts
- Principal investigator: Riad BEJTA, Pt. — Gazi University
- Study coordinator: Meral BOŞNAK GÜÇLÜ, Prof. Dr.
- Email: meralbosnak@gazi.edu.tr
- Phone: +903122162647
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.